The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients


Sozeri B., Sonmez H. E. , Karadag S. G. , Baglan E., Ozturk K., Cakan M., ...More

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.39, no.5, 2021 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 5
  • Publication Date: 2021
  • Journal Name: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Keywords: canakinumab, colchicine resistance, familial Mediterranean fever, CHILDREN

Abstract

Objective. To determine the feasibility of withdrawing canakinumab (CAN) in a large cohort of paediatric patients with colchicine-resistant familial Mediterranean fever (crFMF).